Leuthner Brian A 4
4 · Edge Therapeutics, Inc. · Filed Jun 20, 2018
Insider Transaction Report
Form 4
Leuthner Brian A
Chief Executive Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+338,068→ 338,068 totalExercise: $1.10→ Common Stock (338,068 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.